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 Improving Acute Pain Management for Pediatric Patients: Development of a Ketamine Infusion 
Protocol 
Oksana Koeppen 
Introduction of the Problem 
 In 2001, the American Academy of Pediatrics (AAP) recognized acute pain was 
undertreated in children of all ages. To improve pain control and reduce opioid side effects, the 
American Society of Anesthesiologists (ASA) and the American Pain Society (APS) 
recommended multimodal analgesia for acute pediatric pain management (ASA, 2012; Chou et 
al. 2016). Intravenous ketamine infusions were associated with improved acute pain control in 
children making ketamine a potentially useful adjunct for acute pain management (Dal, Celebi, 
Elvan, Celiker, & Aypar, 2007; Elshammaa et al., 2011; Honarmand, Reza Savi, & Jamshidi, 
2008). A tertiary care center in central Illinois did not possess a pediatric ketamine infusion 
protocol. The purpose of this project was to improve acute pain management for pediatric 
patients by developing a pediatric ketamine infusion protocol for the host facility. 
Literature Review 
 The research has demonstrated ketamine’s usefulness for diverse conditions in the 
pediatric population. The nontraditional use of ketamine in children includes prevention of post-
anesthesia emergence delirium, severe or refractory to traditional treatment status asthmaticus, 
refractory status epilepticus, and breakthrough cancer pain (Abdolkarimi, Zareifar, Eraghi, & 
Saleh, 2016; Bhatnagar et al., 2008; Chiaretti et al., 201; Costi et al., 2014; Dahmani et al., 2010; 
Gaspard et al., 2013; Ilvento et al., 2015; Jat, Azad, & Guglani, 2012; Lu, Wu, & Lu, 2012; 
Sabharwal et al., 2015; Tarocco, Ballardini, & Garani, 2014; Wilkes & Tasker, 2014). Level I 
evidence has concluded prophylactic administration of ketamine reduces postoperative 
  
emergence agitation in children undergoing general anesthesia with volatile agents (Dahmani et 
al., 2011; Dahmani, Delivet, & Hilly, 2014; Eghbal, Taregh, Amin, & Sahmeddini, 2013; Fang, 
Gao, Ge, Zhou, & Zhang, 2016). Level II and III evidence has remained inconclusive of 
ketamine’s benefit for the treatment of status asthmaticus (Jat et al., 2012; Rehder, 2017; Wong, 
Lee, Turner, & Redher, 2014). Level III and IV evidence has demonstrated improved analgesia 
with ketamine administration in pediatric oncology patients when used in combination with 
opioids (Conway, White, Jean, Zempski, & Steven, 2009; Finkel, Pestieau, & Qezado, 2007; 
Kajiume et al., 2012). Contrary to higher level evidence, Level III and IV studies have indicated 
successful ketamine use for treatment of refractory status epilepticus (Gaspard et al., 2013; 
Ilvento et al., 2015, Sabharwal et al., 2015; Tarocco, Ballardini, & Garani, 2014; Wilkes & 
Tasker, 2014).  
Low-dose ketamine infusions are not well-studied in the pediatric population. The 
existing Level I and II evidence has remained divided on the efficacy of subanesthetic ketamine 
infusions in postoperative pain control and reduction in opioid consumption among children 
undergoing surgical procedures (Batra et al., 2007; Cho et al., 2014; Dahmani et al., 2011; 
Michelet et al., 2016). However, multiple high-level studies have consistently demonstrated 
intravenous ketamine effectiveness for acute pain control in children when used as an adjunct to 
other medications including fentanyl, magnesium, dexamethasone, and paracetamol (Asadi et al., 
2016; Cha et al., 2012; Elshammaa et al., 2011; Jabbour et al., 2014; Safavi et al., 2012). Thus, 
incorporating low-dose ketamine infusions into pain management plans and using ketamine as an 
adjunct to other pharmacological agents may allow providers to improve outcomes of pain 
control in children.   
Project Methods 
  
 The purpose of this doctoral project was to improve acute pain management in the 
pediatric population. The goal of the project was to educate healthcare professionals at a tertiary 
care center in central Illinois on current evidence concerning the role of ketamine for pediatric 
patients and encourage them to implement and adopt a low-dose ketamine infusion protocol as a 
modality in the multimodal approach to acute pain management in children. 
 The project utilized a non-experimental design. The design included an educational 
PowerPoint verbal presentation followed by a brief survey. The survey consisted of five 
demographic questions, seven knowledge-based true/false questions, and a 5-point Likert scale 
question. The questionnaire addressed the topics of current recommendations from APS, 
ketamine pharmacology and mechanism of action, and latest literature review findings as well as 
the participants’ likelihood of support for the implementation of the suggested pediatric ketamine 
infusion protocol.  
Before the implementation, the project was reviewed and considered exempt by the 
Institutional Review Board (IRB) from Southern Illinois University Edwardsville and approved 
by the Research Review Committee at the host facility. The participation in the survey was 
voluntary. The risks to human subjects were minimal and included the inconvenience of time and 
emotional distress due to partaking in the survey.  
Evaluation 
 Descriptive statistics and frequency tables were used to define demographics within the 
sample. The seven knowledge-based questions were analyzed by comparison of the percentages 
of correct versus incorrect answer choices in the survey. The overall effectiveness of the 
educational presentation was determined by the evaluation of the percentages of the correct 
  
answer choices. The mean score for the Likert-scale question was calculated to predict the 
likelihood of the support of the pediatric ketamine protocol utilization.     
 Seven survey respondents included one male and six females. Three attendees were 
between the ages 30 and 39, two were ages 40-49, and another two were ages 50-64. Six people 
were White/Caucasian and one was Asian/Pacific Islander. The group included two 
anesthesiologists, two certified registered nurse anesthetists, two pediatric intensive care unit 
registered nurses, and one intensivist. The review of the attendees’ responses to seven 
knowledge-based questions revealed the majority of them gave appropriate answers. The score 
options on the five-point Likert scale ranged from five (strongly agree) to one (strongly disagree) 
and included three as a neutral response. The mean score was 4.3, thus indicating the likelihood 
of staff’s support for the implementation of a pediatric low-dose ketamine infusion protocol. The 
results of the evaluation suggested the educational presentation improved the participants’ 
knowledge concerning acute pediatric pain management and the low-dose pediatric ketamine 
infusion protocol. The results of the survey confirmed the attendees’ support for the 
implementation of the pediatric ketamine infusion protocol.  
The main limitation of this project was the small purposeful sample size. The statistical 
power of the study might be reduced; the variability and bias might be increased. Thus, the 
results of the survey cannot be generalizable to a larger population which includes all staff 
members involved with professional pediatric care at the host institution. 
Impact on Practice 
Healthcare providers in the United States, including the host facility, are challenged with 
governmental and societal pressure to reduce the opioid use in and out of hospital settings. 
Multimodal and opioid-free analgesia is becoming the cornerstone in acute pain management for 
  
adult and pediatric patients. Ketamine is a useful adjunctive alternative for acute pain control in 
children. The steps are being taken to build the order sets based on suggested low-dose ketamine 
infusion protocol and make it available to providers for multimodal pain management approach 
in pediatric care at the host facility. The long-term impact of the project is the sustainability of 
the implementation of a low-dose ketamine infusion protocol for acute pain control in children. 
Consequently, the utilization of the pediatric ketamine infusion protocol at the host facility is 
expected to improve pediatric acute pain management. This project can be replicated and 
expanded hospital-wide on pediatric care units. In the future, the project should include an online 
PowerPoint voiceover presentation which can be reviewed at participants’ convenience. The 
collaborative approach and the involvement of the majority of the staff members who provide 
pediatric care at the host facility are desirable to ensure the continuity of the utilization of the 
low-dose ketamine infusion protocol. The study can be used at any pediatric hospital or any 
hospital providing pediatric health care.  
Conclusion 
 A multimodal approach to analgesia is becoming a prominent modality in pain 
management strategies including pediatric acute pain management. Evidence-based research has 
demonstrated the versatility of use of ketamine in children. Post-anesthesia emergence delirium, 
severe or refractory to traditional treatment status asthmaticus, refractory status epilepticus, and 
breakthrough cancer pain are the conditions in which ketamine use in the pediatric population is 
well-documented. A low-dose ketamine infusion has a potential to improve acute pain control in 
children when used in combination with other pharmacological agents. This project helped to 
educate the healthcare providers at the host facility on current evidence concerning the role of 
ketamine for pediatric patients and encouraged them to implement and adopt a low-dose 
  
ketamine infusion protocol in a multimodal approach to acute pain management in children. The 
results of this project revealed the healthcare providers at the host facility support the use of a 
low-dose ketamine infusion protocol in the pediatric population. The steps are being taken to 
create the order sets based on proposed protocol for implementation at the pediatric intensive 
care unit. Therefore, the availability of the pediatric ketamine infusion protocol for acute pain 
management has the potential to change the healthcare providers approach to pain management 
and improve patients’ outcomes.   
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